CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Documentary Highlights Life and Work of CRI’s Dr. James Allison, 2018 Nobel Laureate

    A new documentary on the life and work of Dr. James Allison, 2018 Nobel Prize winner and…

    September 23, 2019| Arthur N. Brodsky, PhD
  • Charles Graeber Follows Glimmers of Light Leading to the Breakthrough Emergence of Cancer Immunotherapy

    An interview with bestselling author Charles Graeber about his new book, The Breakthrough: Immunotherapy and the Race…

    February 14, 2019| Brian Brewer
  • Six CRI-Funded Scientists on Dr. James P. Allison’s Impact on Their Lives and Careers

    We spoke with six CRI-funded scientists who have worked in Allison’s lab about their experiences and the impact…

    December 6, 2018| Arthur N. Brodsky, PhD
  • Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo

    Dr. Allison’s discoveries and determination led to the development of the first FDA-approved checkpoint immunotherapy

    October 1, 2018| Arthur N. Brodsky, PhD
  • CRI’s James Allison to Receive Prestigious Lasker Award

    The Lasker Foundation announced today that James P. Allison, PhD, director of CRI’s Scientific Advisory Council, is…

    September 8, 2015| Matthew Tontonoz
  • CRI Scientific Advisor James Allison Wins 2014 Szent-Györgyi Prize

    CRI Scientific Advisor James P. Allison, PhD, was awarded the 2014 Szent-Györgyi Prize by the National Foundation…

    February 12, 2014| Matthew Tontonoz
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute